BSEBoard Meeting7h ago · 26 Oct 2026, 04:06 pm
Star Source Multi Trade Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Quarterly financial results for the quarter ended on September 30, 2026.
Star Source Multi Trade Ltd · 506365
✦ AI SummaryResults
Star Source Multi Trade Ltd has scheduled a Board Meeting on November 02, 2026, to consider and approve the Un-Audited Financial Results for the Second Quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Star Source Multi Trade Ltd - 506365 - Board Meeting Intimation for Board Meeting On November 02, 2026
Attachments (1)
📄pdf
Download →
4fc780ba-cce9-4ac8-aa36-4a630fe52cd5.pdf
View document text
STARSOURCE MULTITRADE LIMITED
(Formerly known as Chemo Pharma Laboratories Limited)
(CIN: L46900MH1942PLC003556)
Date: October 26, 2026
Bombay Stock Exchange Limited
Department of Corporate Services,
25th Floor, P. J. Towers, Dalal Street,
Mumbai-400001
Script Id: 506365 ISIN: INE320M01019
Subject: Intimation of Board Meeting under Regulation 29 of Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir / Madam,
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligation and
Disclosure Requirement) Regulations, 2015, we wish to inform you that a meeting of the Board
of Directors of the Company will be held on Monday, November 02, 2026 at the Registered
Office of the Company, inter alia, to transact the following business:
1. To consider and approve the Un-Audited Financial Results for the Second Quarter
ended September 30, 2026 along with the Limited Review Report thereon.
2. Any other matter as Board may deem fit.
Further, in continuation to our intimation and as per the SEBI (Prohibition of Insider Trading)
Regulations 2015, as amended and the Company’s Code of Conduct for Prevention of Insider
Trading (the “Code”), the trading window for dealing in shares of the Company by all designated
persons is closed from October 01, 2026 and the same will continue remain closed and shall
re-open on the expiry of 48 hours after announcement of Un-Audited Financial Results for the
Quarter ended September 30, 2026.
The same may please be taken on record.
Thanking You.
Yours Faithfully,
FOR Starsource Multitrade Limited
(Formerly known as Chemo Pharma Laboratories Limited)
RUCHIT MEHTA
Managing Director & Chief Executive Officer
DIN: 08810586
Registered Office: 5 - Kumud Apartment CHS Ltd, Karnik Road, Chikan Ghar, Kalyan,– 421301, India
Corporate Headquarter: 1016, North Plaza, Near D Mart, Motera, Ahmedabad– 380005, India
Ph: +91-22-22078381 / 82 | Fax: +91-22-22074294
Email: chemopharmalaboratorieslimited@gmail.com | www.starsourcemultitrade.com